Little is known about the behaviour of central retinal vein occlusion (CRVO) in the young. We studied the course and visual outcome in 25 patients with CRVO aged less than 40 years with special reference to the association with underlying systemic disorders. Eight patients had ischaemic CRVO while 17 had non-ischaemic CRVO. 
Central retinal vein occlusion (CRVO) is seen typically in the elderly population and is often associated with hyper tension, 1 arteriosclerosis,2 hypercoagulable states3 or glaucoma. 4 It comprises two distinct entities: a mild non ischaemic and a severe ischaemic variety. 5 In reported series up to 10% of the CRVO patients are less than 40 years of age.6,7 In the young, CRVO has been reported to be frequently mild and non-ischaemic,8 though occur rence of ischaemic CRVO is not unknown.9 This prospec tive study describes our observations of ischaemic CRVO in 8 patients, with special reference to its severity, course, visual outcome and the pathogenetic role of underlying systemic disorders.
MATERIAL AND METHODS
Twenty-five consecutive patients aged 40 years or less suf fering from CRVO who came under our observation All other cases were classified as non-ischaemic CRVO.
RESULTS
Of the 25 patients (29 eyes) studied, 8 (9 eyes) had ischaemic CRVO while 17 (20 eyes) had non-ischaemic CRVO. Of the 8 patients with ischaemic CRVO, 5 were male and 3 female in the age range 24-40 years. Fol low-up of ischaemic CRVO varied from 3 to 18 months (mean 9.4). Six of 8 patients (75%) with ischaemic CRVO had associated known risk factors (Table I ). These were end-stage renal disease in 3 and hypercholesterolaemia (serum cholesterol 500 mg%), essential hypertension (diastolic blood' pressure between 110 and 120 mmHg) and \3-thalassaemia with pregnancy in 1 patient each. The clinical course of the 8 patients with ischaemic CRVO is summarised in Table II . Two illustrative patients are described. Case 3. A 27-year-old woman was found to be suffering from idiopathic diffuse crescentic glomerulonephritis in February 1990 and was started on a biweekly maintenance haemodialysis programme. In December 1990 blood pres sure was 180/120 mmHg and she complained of rapid diminution of vision in both eyes. Visual acuity was 6/36 in the right eye and 6/18 in the left. Anterior segment examination was unremarkable. Fundus examination revealed bilateral optic disc oedema, multiple cotton wool spots, macular star and acute Elschnig's spots, suggestive of bilateral malignant hypertensive retinopathy and chor oidopathy. Following 4 weeks of antihypertensive therapy the ocular signs resolved and visual acuity improved to 6/6 in each eye. In February 1991 she developed sudden diminution of vision in her left eye. The visual acuity was 6/6 in the right eye and limited to counting fingers at 13 metre in the left eye. Examination revealed a left afferent pupillary defect. On fundoscopy, massive oedema of optic disc and macula, multiple cotton wool spots and large ret-inal haemorrhages were seen in all four quadrants (Fig. 1 ). On fluorescein angiography there was venous stasis and multiple areas of capillary non-perfusion (Fig. 2) . Visual fields of the left eye showed peripheral constriction and a large central scotoma. The changes were consistent with ischaemic CRVO of the left eye. The patient underwent prophylactic krypton red panretinal photocoagulation (PRP) and was followed regularly at 2-weekly intervals. Six months later she developed retinal neovascularisation elsewhere (NVE) with a preretinal bleed (Fig. 3) . At this stage she was detected to be positive for antibodies to human immunodeficiency virus (HIV) while OD mainten ance haemodialysis, and died a month later.
Case 6. A 26-year-old man suffering from membra noproliferative glomerulonephritis and end-stage renal failure underwent a live unrelated renal transplant on 17 February 1990, and was receiving immunosuppressive therapy. In March 1990 he developed leucopenia, oeso phageal candidiasis and mild hypertension followed by sudden loss of vision in the right eye. Visual acuity was reduced to light perception in the right eye and was 6/6 in the left. An afferent pupillary defect was present in the right eye. On fundoscopy the optic disc was swollen with multiple confluent cotton wool spots on and around the optic disc and posterior pole. The veins were engorged and 'box-carring' of the venous column was evident (Fig. 4) . On fundus fluorescein angiography the arterioles were attenuated with delayed filling of a few veins (Figs. 5 and 6).
Four weeks later he developed new vessels on the optic disc (NVD). While awaiting panretinal photocoagulation he developed severe neovascular glaucoma (NVG; intra ocular pressure 70 mmHg) in the right eye within 6 weeks of venous occlusion. Medical control of glaucoma allowed sufficient clarity of the media to carry out a full- Hyperchol.
Nil. scale krypton laser PRE He required trabeculectomy with adjuvant 5-fluorouracil (total dose 10 x 5 mg) for control of glaucoma. The eye, however, became hypotonic, result ing in phthisis bulbi over the next 6 months. He died from di sseminated fungal infection in J ul y 1991 despite anti fungal therapy.
Ocular Complications and Management
All the 9 affected eyes of the 8 patients developed ocular neovascularisation 1-6 months after the onset of vascular occlusion: NVD/NVE alone in 4 eyes, NVG alone in 2 eyes, and NVD/NVE with NVG in 3 eyes. Krypton laser panretinal photocoagulation was done in 7 eyes either pro phylactically (case 3) or at the time of detecting ocular neovascularisation, and caused regression in all the treated eyes except in case 3. One eye (case 8) required anterior A. GUPTA ET AL.
retinal cryopexy in addition. Of the 4 eyes with only NVD/ NVE, complete regression of neovessels occurred with laser scatter alone in 3 eyes. Of the 5 eyes with NVG, tra beculectomy with adjuvant 5-fluorouracil was performed in 3 eyes after achieving control of ocular neovascular isation. In 2 eyes (cases 2 right eye and 8) glaucoma was controlled and 1 eye (case 6) ended in phthisis bulbi. Two eyes (cases 2 left eye and 7) subjected to cyclocryopexy alone developed phthisis bulbi. Finally, the ocular neovas cularisation could be controlled in 5 eyes with visual acuity varying from no light perception to 6/60. All 3 patients with end-stage renal disease died within 10-15 months of the onset of vascular occlusion.
DISCUSSION
Central retinal vein occlusion is considered a disease of the elderly, with more than 90% of cases occurring in patients over 50 years of age. 4 The condition is often asso ciated with systemic vascular disease and more than half of patients suffer from hypertension and one-third from diabetes mellitus and atheroslcerotic heart disease. 4 , 12
Other causes of CRVO include abnormalities in the vessel wall and alterations in the clotting mechanisms and blood viscosity. 3 . 4 Since the majority of the patients who have been observed are in the older age group, the disease pat tern in the younger subjects has not been highlighted. Review of the literature has revealed only a few patients with CRVO under the age of 40 years. 6 . 8 . 9 Walters and Spalton 8 found only 21 of 182 patients with CRVO younger than 40 years of age. Detailed review of 17 of these patients revealed that all of them suffered from non ischaemic CRVO with a benign course and a good visual outcome. None of them had any associated systemic disease. These authors concluded that CRVO in the young is probably a different disease from that seen in the elderly and retillal haemorrhagcs, because of its unil aterality and excellent visual prognosis .
In contrast, Priluck £'1 of'" observed complete CRVO in half of their 42 patients aged 40 years or less. Eight of these 42 ( 14%) had a recognised systemic disorder at the time of initial ocular diagnosis, which was incomplete CRVO in 3 and complete CRVO in S. There was no sig nificant difference in the incidence of systemic disorders between the two groups.
In the present stud y R of 2S patients suffered from ischaemic CRVO and6 of these R OSCIr) had an associated systemic disorder. All 3 patients with renal disease had secondary hypertension with diastolic blood pressure varying between 120 and 130 mmHg. Retinal vein occlu sion in these patients could have involved a complex inter- a(J documented ischaemic CRVO in 7 of I I young adults.
All of them had poor visual acuity and 4 had a systemic disorder at the onset. The visual ac uity in 6 of 7 patients w it h ischaemic CRVO wa s less than 3/60 at onset and remained so until the last follow -up . Though a sign ifi cant association was o bserved between ischaemic CRVO and systemic disorder. the severi ty of the systemic disease was not highlighted by the authors ."
The most significant tinding in our study was the rapid evolution of the ocular disorder in the ischaemic group.
The in it ia l visual acuity in 7 eyes was limited to counting rapid progression, we suggest early prophylactic PRP in young patients with an underlyjng serious systemic dis order. In the series by Priluck et al.,6 3 of 24 eyes with complete CRVO developed NVG necessitating enuclea tion. Visual acuity improved in 9 eyes, while 7 eyes showed no change. Three patients with incomplete CRVO and 2 with complete CRVO died during follow-up. The time between the diagnosis of venous occlusion and death ranged from 9 to 23 years with a mean of 15 years. In con trast, 3 of our patients died within 15 months of ocular diagnosis, because of the serious nature of the underlying systemic disorder. Our findings disprove the popular belief that CRVO in the young is mostly mild and has a universally good prog nosis. One-third of our patients suffered severe ischaemic CRVO and had a rapid downhill course with poor visual outcome. Prognosis was grave in patients with CRVO associated with end-stage renal disease. Early and effec tive management is mandatory to prevent serious ocular and life-threatening complications.
